Literature DB >> 17084604

Beta-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma.

S-Y Jeon1, S-H Kwon, Y-H Seong, K Bae, J-M Hur, Y-Y Lee, D-Y Suh, K-S Song.   

Abstract

In the course of searching for BACE1 (beta-secretase) inhibitors from natural products, the ethyl acetate soluble fraction of Smilax Rhizoma (the dried rhizomes of Smilax china L.) showed potent inhibitory activity. The active compounds were identified as a trans/cis-resveratrol mixture, oxyresveratrol, veraphenol, and cis-scirpusin A. They were shown to non-competitively inhibit BACE1 with the Ki values of 5.4 x 10(-6), 5.4 x 10(-6), 3.4 x 10(-6), and 5.4 x 10(-6)M and IC(50) values of 1.5 x 10(-5), 7.6 x 10(-6), 4.2 x 10(-6), and 1.0 x 10(-5)M, respectively. The active compounds were less inhibitory to alpha-secretase (TACE) and other serine proteases such as chymotrypsin, trypsin, and elastase, suggesting that they were relatively specific inhibitors of BACE1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084604     DOI: 10.1016/j.phymed.2006.09.003

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  10 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

Review 2.  Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.

Authors:  Xian-Le Bu; Praveen P N Rao; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

Review 3.  Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.

Authors:  Akanksha Kulshreshtha; Poonam Piplani
Journal:  Neurol Sci       Date:  2016-06-01       Impact factor: 3.307

4.  Identification of Neuroactive Constituents of the Ethyl Acetate Fraction from Cyperi Rhizoma Using Bioactivity-Guided Fractionation.

Authors:  Yeomoon Sim; Jin Gyu Choi; Pil Sung Gu; Byeol Ryu; Jeong Hee Kim; Insug Kang; Dae Sik Jang; Myung Sook Oh
Journal:  Biomol Ther (Seoul)       Date:  2016-07-01       Impact factor: 4.634

Review 5.  Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.

Authors:  Stephanie Andrade; Maria João Ramalho; Maria do Carmo Pereira; Joana A Loureiro
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

Review 6.  Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Sohanur Rahman; Tapan Behl; Philippe Jeandet; Ghulam Md Ashraf; Agnieszka Najda; May N Bin-Jumah; Hesham R El-Seedi; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

7.  Quantum Mechanical Predictions of the Antioxidant Capability of Moracin C Isomers.

Authors:  Angela Parise; Bruna Clara De Simone; Tiziana Marino; Marirosa Toscano; Nino Russo
Journal:  Front Chem       Date:  2021-04-21       Impact factor: 5.221

8.  Integrating network pharmacology analysis and pharmacodynamic evaluation for exploring the active components and molecular mechanism of moutan seed coat extract to improve cognitive impairment.

Authors:  Yue Wang; Xinyan Wu; Kailin Yang; Qing Liu; Baoping Jiang; Runmei Yang; Peigen Xiao; Chunnian He
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

9.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

10.  Antioxidant Compound, Oxyresveratrol, Inhibits APP Production through the AMPK/ULK1/mTOR-Mediated Autophagy Pathway in Mouse Cortical Astrocytes.

Authors:  Md Ataur Rahman; Yoonjeong Cho; Ghilsoo Nam; Hyewhon Rhim
Journal:  Antioxidants (Basel)       Date:  2021-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.